Value HR (6078) FY2026 Q1 Earnings Report

Quick View

Executive Summary

FY2026 Q1 results: Revenue ¥25.6B (vs prior year +¥2.9B +12.6%), Operating Income ¥1.9B (vs prior year -¥0.5B -21.5%), Ordinary Income ¥2.1B (vs prior year -¥0.5B -18.0%), Net Income ¥1.3B (vs prior year -¥0.3B -18.7%). Revenue maintained double-digit growth, but gross margin fell from 32.6% to 27.8% (-4.8pt), and operating margin contracted from 11.0% to 7.6% (-3.3pt). The core Value Cafeteria Business reported revenue ¥20.8B (+13.1%) but segment profit ¥4.0B (-15.9%), with segment margin declining from 25.9% to 19.3%. Conversely, the HR Management Business posted revenue ¥4.8B (+10.3%) and segment profit ¥0.9B (+72.7%), with margin improving from 12.3% to 19.2%. Non-operating results included securities disposal gains of ¥0.3B supporting the ordinary level, but increased interest burden (interest expense ¥0.2B vs prior year ¥0.1B) and an effective tax rate of 36.9% curtailed net income growth. The quarter resulted in revenue up but profit down; restoring profitability is a key issue.

Drivers of Performance

[Revenue] Revenue was ¥25.6B (+12.6% YoY), achieving double-digit growth. By segment, the Value Cafeteria Business accounted for ¥20.8B (+13.1%), representing 81% of total; breakdown: Healthcare ¥15.6B (+17.1%), Cafeteria ¥4.8B (+2.9%). HR Management Business was ¥4.8B (+10.3%), driven by services centered on health insurance administration and related offerings. Contract-derived revenue from customers was ¥24.8B (+12.9%), and other revenue (real estate leasing, etc.) was ¥0.8B (+5.2%). Revenue growth was mainly due to expansion of the customer base and deepening of existing contracts in the healthcare area.

[Profitability] Cost of sales rose to ¥18.5B (+20.6%), increasing faster than revenue growth, resulting in gross profit of ¥7.1B (-3.9%). Gross margin declined to 27.8% from 32.6% a year earlier (-4.8pt), indicating a deterioration in cost structure. SG&A was ¥5.2B (+5.0%), growing below revenue growth, so fixed-cost control functioned, but could not offset gross profit contraction; Operating Income fell to ¥1.9B (-21.5%), and Operating Margin decreased to 7.6% (prior year 11.0%). By segment, Value Cafeteria segment profit was ¥4.0B (-15.9%), segment margin 19.3% (prior year 25.9%) showing marked deterioration, while HR Management recorded profit ¥0.9B (+72.7%), margin 19.2% (prior year 12.3%) showing improvement. Corporate expenses were ¥3.0B (prior year ¥2.8B), further compressing operating income. Non-operating income included interest income ¥0.0B and securities disposal gains ¥0.3B, totaling non-operating income ¥0.3B; non-operating expenses were ¥0.2B driven by interest expense ¥0.2B (prior year ¥0.1B). Ordinary Income was ¥2.1B (-18.0%), Ordinary Margin 8.1% (prior year 11.1%) (-3.0pt). After deducting corporate tax, etc. of ¥0.8B (effective tax rate 36.9%), Net Income was ¥1.3B (-18.7%), Net Margin 5.1% (prior year 7.0%). In summary, it was a quarter of revenue growth but profit decline; gross margin contraction and higher non-operating interest burden depressed profitability.

Segment Analysis

Value Cafeteria Business: Revenue ¥20.8B (+13.1%), Segment Profit ¥4.0B (-15.9%), Segment Margin 19.3% (prior year 25.9%). Although revenue increased, margin deteriorated by 6.6pt due to a decline in gross margin. Healthcare posted ¥15.6B (+17.1%) maintaining high growth, but rising cost ratios and changes in service mix likely pressured profitability. Cafeteria was ¥4.8B (+2.9%) with low growth. HR Management Business: Revenue ¥4.8B (+10.3%), Segment Profit ¥0.9B (+72.7%), Segment Margin 19.2% (prior year 12.3%), showing revenue and profit growth with a 6.9pt margin improvement. Services such as health insurance administration were strong at ¥4.4B (+10.4%), contributing to improved profitability. Corporate unallocated expenses were ¥3.0B (prior year ¥2.8B), reducing operating income to ¥1.9B. Across segments, margin deterioration in the core Value Cafeteria business was the main driver of company-wide profit declines, partly offset by HR Management improvement.

Key Financial Metrics

[Profitability] Operating Margin 7.6% (prior year 11.0%), Net Margin 5.1% (prior year 7.0%) declined. Gross Margin 27.8% (prior year 32.6%) contracted by 4.8pt, indicating cost-structure deterioration pressured profitability. ROE was 2.0%, low, explained by Net Margin 5.1%, Total Asset Turnover 0.144, and Financial Leverage 2.67x. The main cause of ROE decline was contraction in Net Margin; contributions from asset efficiency and leverage were limited. [Cash Quality] Days Sales Outstanding (DSO) extended to 124 days, lengthening the cash conversion lag from revenue recognition. Non-operating income was ¥0.3B, or 1.2% of revenue, including securities disposal gains of ¥0.3B, but dependency is limited. [Investment Efficiency] Total Asset Turnover is low at 0.144, and despite revenue growth asset efficiency did not improve. Prolonged DSO weighed on asset turnover. [Financial Soundness] Equity Ratio was 37.4% (prior year 37.7%), roughly flat, indicating stable financial base. Interest-bearing debt was ¥57.2B (short-term borrowings ¥11.4B, long-term borrowings ¥45.8B), with D/E ratio 0.86x, not excessive. Current Ratio was 96.8% (below 1.0x), warranting attention to short-term liquidity, but cash and deposits of ¥38.6B provide coverage: Cash/Short-term Debt 3.39x, Interest Coverage 10.76x, indicating solid ability to pay. Short-term borrowings increased from ¥3.5B to ¥11.4B, making maturity mismatch management important.

Cash Flow Analysis

Non-operating income ¥0.3B included securities disposal gains ¥0.3B, supporting the ordinary level but being a temporary factor. With DSO at 124 days, the lag between revenue recognition and cash conversion is large, risking working capital tie-up and delayed cash conversion of profits. Cash and deposits were ¥38.6B, down ¥10.7B (-21.7%) from ¥49.3B a year earlier, shrinking the cash buffer. Short-term borrowings increased by ¥7.9B from ¥3.5B to ¥11.4B, suggesting responses to working capital needs or cash outflows. Deposits received (advance receipts, etc.) decreased to ¥26.5B from ¥36.7B (down ¥10.2B, -27.9%), easing current liabilities but altering working capital structure. Interest burden increased (interest expense ¥0.2B vs prior year ¥0.1B), pressuring free cash flow. Strengthening collection of accounts receivable, optimizing billing cycles, and reviewing the maturity profile of interest-bearing debt are keys to improving cash efficiency.

Quality of Earnings

Operating Income ¥1.9B is the core of recurring earnings, reflecting the company’s operating earning power. Non-operating income ¥0.3B included securities disposal gains ¥0.3B, representing 1.0% of revenue and indicating limited reliance on one-off items. Other non-operating income was minimal (interest income ¥0.0B, dividend income ¥0.0B), indicating low dependence on financial income. Non-operating expenses were ¥0.2B centered on interest expense ¥0.2B, and the rising interest burden compressed Ordinary Income. The effective tax rate is 36.9%, relatively high, restraining Net Income growth. Comprehensive Income was ¥0.6B, below Net Income ¥1.3B, driven by negative other comprehensive income from valuation differences on securities (OCI -¥0.7B). Valuation differences decreased by ¥0.7B from ¥2.4B to ¥1.6B, showing market-driven capital volatility. The gap between Net Income and Ordinary Income is mainly explained by tax expense; no material extraordinary items were observed. Earnings quality is generally recurring, but declining gross margin and prolonged DSO lower cash conversion of profits; improving working capital management is key to enhancing earnings quality.

Forecasts & Guidance

Full Year guidance is unchanged: Revenue ¥110.0B (+9.3% YoY), Operating Income ¥16.5B (+86.9%), Ordinary Income ¥16.3B (+70.3%), Net Income ¥10.5B, EPS ¥39.31. Q1 progress rates: Revenue 23.2% (vs standard 25% -1.8pt) roughly on track, but Operating Income 11.8% (vs standard -13.2pt), Ordinary Income 12.6%, Net Income 12.4% — all significantly behind on the profit side. The >10% shortfall in Operating Income progress is large, attributable to Q1 gross margin decline (32.6% → 27.8%), front-loading of corporate expenses (¥3.0B vs prior year ¥2.8B), and increased interest burden (interest expense ¥0.2B vs prior year ¥0.1B). Achieving the full-year target will require margin normalization from Q2 onward (price revisions, procurement optimization, higher proportion of high-value-added services), seasonal absorption of SG&A, and improved working capital efficiency (DSO shortening). Dividend guidance has been revised up to ¥14.5 per annum, implying a payout ratio of approximately 36.9% on Full Year EPS ¥39.31. No revision to earnings guidance has been made; the company assumes achieving full-year targets, but Q1 progress indicates that a rebound in the first half is important.

Shareholder Returns

Dividend guidance was revised up to ¥14.5 per year, an increase of ¥1.5 from last fiscal year’s ¥13.0. The payout ratio on full-year EPS forecast ¥39.31 is about 36.9%, a level balancing retained earnings. Q1 EPS was ¥4.88 (prior year ¥6.02), showing quarter-on-quarter profit decline, but the company maintained the dividend increase policy assuming recovery over the fiscal year. Cash and deposits of ¥38.6B secure dividend funding. Treasury stock is ¥6.8B (about 2.5% of outstanding shares), and additional total return capacity depends on the performance track. If interest burden rises and working capital tie-up continues, free cash flow could become volatile, so dividend sustainability depends on recovery in full-year profitability and cash generation. The payout policy is within a prudent range, and dividend continuation seems feasible despite short-term performance volatility, but monitoring progress on margin improvement is necessary.

Risk Factors

1. Risk of prolonged gross margin decline: Gross Margin fell to 27.8% from 32.6% a year earlier (-4.8pt), and Operating Margin shrank to 7.6% (prior year 11.0%). The Value Cafeteria business’s segment margin dropped to 19.3% (prior year 25.9%) (-6.6pt), likely due to rising costs and changes in service mix. If price adjustments and procurement optimizations are delayed, margin recovery may stall and achieving the full-year guidance (Operating Margin 15.0%) could become difficult.

2. Short-term liquidity and maturity mismatch risk: Current Ratio is 96.8% (below 1.0x), so short-term liquidity requires attention. Short-term borrowings rose to ¥11.4B from ¥3.5B, an increase of ¥7.9B, indicating increased short-term financing for working capital needs. With DSO at 124 days, continued delays in accounts receivable collection could delay cash conversion, exacerbating refinancing risk and higher interest burden. Cash and deposits of ¥38.6B and Interest Coverage of 10.76x indicate current payment capacity is solid, but managing maturity mismatch is important.

3. Risk of declining working capital efficiency: DSO at 124 days remains prolonged, and asset efficiency has not improved despite revenue growth. Total Asset Turnover is low at 0.144, and receivables accumulation pressures working capital. Deposits received (advance receipts, etc.) decreased to ¥26.5B from ¥36.7B (down ¥10.2B), changing the working capital structure. If collection terms are not shortened and billing cycle optimization does not progress, combined with gross margin deterioration, cash conversion of profits may weaken and free cash flow generation may be delayed.

Industry Benchmark (Reference, Company Analysis)

Profitability & Returns

Profitability exceeds the industry median, but the decline from the prior year is large and the company’s relative advantage within the sector is shrinking.

Growth & Capital Efficiency

Revenue growth lags the industry median by 8.3pt, indicating a relatively slower growth pace within the IT & Communications sector.

※Source: Company compilation

Points of Focus in the Earnings Report

1. Gross margin normalization and certainty of full-year margin recovery are paramount: Q1 achieved Revenue growth +12.6% but gross margin fell by 4.8pt, and Operating Margin narrowed to 7.6% (prior year 11.0%). Full-year guidance anticipates Operating Income +86.9% (a significant increase), but Q1 progress was only 11.8% of target, a large shortfall. Whether margin improvements from price adjustments, procurement optimization, and raising the share of high-value-added services materialize from Q2 onward will determine full-year attainment. It is critical to monitor whether the core Value Cafeteria segment margin recovers from 19.3% (prior year 25.9%), and whether HR Management’s higher margins (19.2%, prior year 12.3%) can drive company-wide improvement.

2. Improvement in working capital efficiency and restoration of cash generation: DSO at 124 days remains prolonged and asset efficiency has not improved alongside revenue growth. With Current Ratio 96.8% and increased short-term borrowings (¥11.4B vs prior year ¥3.5B), short-term liquidity requires attention, though cash ¥38.6B currently supports payment capacity. Strengthening receivables collection and optimizing billing cycles to reduce working capital tie-up will be important to restore free cash flow generation and balance dividend sustainability (payout ratio 36.9%) with growth investment. Increased interest burden (interest expense ¥0.2B vs prior year ¥0.1B) also depresses profitability, so revising the maturity profile of interest-bearing debt and reducing interest costs are required.

---

This report is an AI-generated earnings analysis document produced by analyzing XBRL financial statement data. It is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled by the Company based on public financial statements. Investment decisions are your own responsibility; please consult a professional advisor as necessary before making any investment decisions.

---

AI Financial Analysis

Executive Summary

FY2026 Q1 was a mixed quarter: revenue expanded at a double-digit pace, but profit growth deteriorated materially as gross-margin compression outweighed higher sales. Revenue rose 12.6% year on year to ¥2.56bn. Operating income declined 21.5% to ¥195m, while ordinary income fell 18.0% to ¥206m and net income attributable to owners decreased 18.7% to ¥130m. The operating margin contracted to 7.6% from 11.0% in the prior-year quarter, a 340bp decline. Gross margin declined to 27.8% from 32.6%, a 480bp contraction, indicating that cost of sales grew substantially faster than revenue. SG&A rose 5.0% to ¥515m, slower than revenue growth, but the gross-profit decline still reduced operating leverage. The Value Cafeteria business remained the largest earnings contributor, generating segment profit of ¥401m, although this was down 15.9% year on year. HR Management delivered a strong recovery, with segment profit increasing 72.8% to ¥92m, but its smaller earnings base was insufficient to offset the decline in the core business. Consolidated operating income was further reduced by unallocated corporate costs of ¥297m, up 5.8% year on year. Non-operating income included a ¥25m gain on sales of investment securities, which modestly supported ordinary income but does not represent recurring operating performance. Net profit margin was 5.1%, down from approximately 7.1% a year earlier. Reported annualized ROE was 7.8%, at the threshold below which profitability is generally less compelling under the stated benchmark. Liquidity is tight, with current assets of ¥6.05bn below current liabilities of ¥6.25bn and working capital negative by ¥199m. The full-year forecast implies a sharp earnings recovery in the remaining quarters, particularly in operating income. Full-year revenue guidance remains unchanged, while the company has revised its dividend outlook upward to ¥28 per share. The principal issue for subsequent quarters is whether healthcare-led sales growth can be converted back into gross-profit expansion while corporate costs and debt-funded liquidity needs remain controlled.

Profitability Analysis

The reported annualized DuPont ROE of 7.8% is composed of a 5.1% net profit margin, 0.577x asset turnover, and 2.67x financial leverage. The weakest component is the net margin, reflecting the substantial year-on-year decline in operating profitability. EBIT margin was 7.6%, down from 11.0% in FY2025 Q1, while gross margin fell 480bp to 27.8%; this identifies cost-of-sales pressure as the primary driver of earnings deterioration. Financial leverage remains meaningful at 2.67x and supports ROE, but it also means shareholder returns are dependent on maintaining adequate operating earnings and debt servicing capacity. Asset turnover is reasonable for the asset base, which includes ¥8.78bn of property, plant and equipment, notably ¥6.37bn of land, but it is not sufficient to offset the margin decline. SG&A increased 5.0%, materially below the 12.6% revenue increase, demonstrating some cost discipline; however, gross profit declined 3.9% to ¥711m because cost of sales rose 20.6%. Value Cafeteria segment revenue increased 13.1% to ¥2.08bn, but segment profit fell 15.9% to ¥401m and its segment margin declined to 19.3% from 25.9%. HR Management revenue increased 10.3% to ¥476m and segment profit rose 72.8% to ¥92m, lifting its segment margin to 19.2% from 12.3%. Thus, the core business remains Value Cafeteria by segment-profit contribution, but its margin normalization is the critical profitability variable. The tax burden factor was 0.629, corresponding to a 36.9% effective tax rate, and reduced the conversion of pre-tax income to net income. The interest burden factor exceeded 1.0 because non-operating gains exceeded net interest expense, although the investment-security gain is non-recurring and should not be treated as a structural enhancement to profitability.

Growth Assessment

Top-line momentum is positive, led by healthcare revenue, which increased 17.1% year on year to ¥1.56bn. Cafeteria revenue increased 2.9% to ¥480m, while health-insurance administration and related service revenue rose 10.4% to ¥438m. Revenue from customer contracts rose to ¥2.48bn from ¥2.19bn, supporting the view that the growth is rooted in the operating businesses rather than other revenue. Other revenue, including real-estate rental income, was broadly stable at ¥81m. The main challenge is growth quality: the 12.6% revenue gain translated into a 21.5% operating-income decline because the incremental revenue carried materially lower gross profitability. Against full-year guidance of ¥11.0bn, Q1 revenue represents 23.2% progress, 1.8 percentage points below the standard 25% quarterly run rate. Q1 operating income of ¥195m represents only 11.8% of the ¥1.65bn full-year forecast, 13.2 percentage points below a standard Q1 progress rate. Net income progress is similarly low at 12.4% of the ¥1.05bn forecast. The unchanged full-year operating-income forecast of ¥1.65bn implies an 86.9% year-on-year increase and requires substantial margin recovery through the remaining nine months. The full-year forecast therefore appears back-end loaded, with execution dependent on improved gross margin in Value Cafeteria, continued HR Management profit expansion, and containment of unallocated corporate expenses.

Financial Health

Liquidity requires explicit attention: the current ratio and quick ratio are both 0.97x, below 1.0x, and working capital is negative ¥199m. Current liabilities of ¥6.25bn exceed current assets of ¥6.05bn, creating a short-term maturity mismatch that requires dependable operating cash generation, refinancing capacity, or use of cash balances. Cash and deposits of ¥3.86bn remain sizeable and cover short-term loans of ¥1.14bn by 3.39x, which provides a near-term liquidity buffer. However, cash declined ¥1.07bn year on year, while short-term loans increased ¥792m, or 226.7%, to ¥1.14bn. This shift toward short-term borrowing is the root cause of the low-liquidity alert: current funding requirements have increased even though the company retains a meaningful cash balance. Long-term loans declined ¥685m to ¥4.58bn, meaning the increase in short-term debt partly reflects a maturity-profile shift rather than a large increase in aggregate indebtedness. Total interest-bearing debt was ¥5.72bn, debt-to-equity was 1.67x, and debt/capital was 46.3%. D/E does not exceed the 2.0x aggressive-leverage warning threshold, but it remains elevated for a company whose Q1 operating margin has compressed. Interest coverage was 10.76x, which is strong and indicates that current EBIT covers interest expense of ¥18m adequately. The balance sheet is asset-heavy, with PPE accounting for 49.6% of total assets and land alone totaling ¥6.37bn; this asset base may offer balance-sheet resilience but also constrains asset turnover. Equity declined to ¥6.63bn from ¥6.90bn, principally alongside a negative ¥74m movement in valuation differences on securities within other comprehensive income and lower retained earnings. Intangible assets represented a moderate 6.3% of assets, below the stated concentration warning level.

Notable B/S Changes

Short-term loans: +¥0.79bn (+226.7%) to ¥1.14bn - material increase in short-term funding and a contributor to the 0.97x current ratio; monitor refinancing needs and cash deployment. Cash and deposits: -¥1.07bn (-21.7%) to ¥3.86bn - reduced liquidity buffer, although cash remains 3.39x short-term loans. Long-term loans: -¥0.69bn (-14.7%) to ¥4.58bn - partial offset to higher short-term debt, indicating a shift in debt maturity profile rather than a substantial rise in total borrowing. Total equity: -¥0.27bn (-4.0%) to ¥6.63bn - lower retained earnings and a negative securities valuation movement reduced the capital buffer. Valuation difference on securities: -¥0.07bn year on year to ¥0.16bn - market-value movements reduced comprehensive income and demonstrate sensitivity of equity to investment-security valuations.

Cash Flow Quality

Operating cash flow, investing cash flow, financing cash flow, capital expenditure, and free cash flow are not reported in the available data; accordingly, cash-conversion and free-cash-flow coverage metrics cannot be assessed. Earnings quality is nevertheless moderated by the fact that ordinary income included a ¥25m gain on sales of investment securities, equal to approximately 12.3% of ordinary income. This gain is not a recurring operating earnings source and partly offsets the decline in operating income. Net income of ¥130m was below ordinary income of ¥206m primarily because of ¥76m of income tax expense, producing a 36.9% effective tax rate. The year-on-year decline in cash and deposits of ¥1.07bn, together with the rise in short-term borrowings, makes subsequent cash-flow disclosure important for assessing the durability of liquidity.

Dividend Sustainability

The company has revised its full-year dividend forecast upward to ¥28 per share. Based on forecast EPS of ¥39.31, the implied dividend payout ratio is approximately 71.2%. This is above the stated 60% sustainability benchmark, leaving a narrower earnings retention buffer than a conservative payout policy. The forecast payout remains below 100%, so the dividend is covered by forecast accounting earnings if the full-year plan is achieved. However, Q1 EPS was ¥4.88, only 12.4% of the annual EPS forecast, emphasizing that dividend coverage depends on a substantial earnings acceleration after Q1. The balance sheet also has negative working capital and ¥5.72bn of interest-bearing debt, so liquidity preservation and debt management should be considered alongside shareholder distributions. The available data do not show cash-flow coverage of dividends; therefore, the capacity to fund dividends after capital expenditure and debt service cannot be quantified.

Risk Assessment

Business risks include Gross-margin risk is the highest operating risk: gross margin fell 480bp to 27.8%, and revenue growth did not translate into earnings growth., Value Cafeteria, the core business by segment profit, recorded a 15.9% decline in segment profit despite 13.1% revenue growth; continued margin pressure in this segment would challenge the full-year earnings recovery., The full-year operating-income plan requires a pronounced improvement from Q1's 11.8% progress rate, creating execution risk in the remaining quarters., For an HR and healthcare-service provider, service quality, system reliability, customer-data protection, and retention of specialized personnel are industry-specific risks that could affect contract continuity and profitability..

Financial risks include The current ratio of 0.97x is below 1.0x. The root cause is current liabilities of ¥6.25bn exceeding current assets of ¥6.05bn; while cash covers short-term loans, the maturity mismatch heightens reliance on cash generation and funding access., Short-term loans increased 226.7% year on year to ¥1.14bn. This funding-profile shift raises refinancing and liquidity sensitivity, particularly if earnings recovery is delayed., Debt-to-equity of 1.67x and debt/capital of 46.3% are not at aggressive-warning levels but leave less balance-sheet flexibility than a low-leverage structure., Comprehensive income fell 65.0% to ¥56m because of a ¥74m negative valuation difference on securities, illustrating exposure of equity to market-price movements in investment securities..

Key concerns include The high work-in-process ratio alert reflects work in process of ¥20m relative to merchandise inventory of ¥0.5m. In an otherwise low-inventory service business, monitoring project execution, billing timing, and potential cost overruns is appropriate; the absolute amount is small relative to assets., Non-operating investment-security gains supported Q1 ordinary income, so underlying recurring profitability was weaker than the ordinary-income line alone suggests., Unallocated corporate costs increased to ¥297m from ¥280m, limiting the translation of segment profitability into consolidated operating income., The investment case will be sensitive to whether healthcare revenue growth can be maintained while restoring Value Cafeteria gross margin..

Investment Implications

Key takeaways include Revenue growth was robust at 12.6%, led by healthcare revenue growth of 17.1%., Profitability weakened materially, with operating margin down 340bp to 7.6% and net margin down to 5.1%., HR Management showed a meaningful segment-profit recovery, but Value Cafeteria remains the dominant profit contributor and experienced margin compression., The annualized ROE of 7.8% is supported by leverage rather than strong operating margins., Liquidity is manageable but tight, given the 0.97x current ratio, negative working capital, and increased short-term borrowing., The revised ¥28 per-share dividend implies a relatively high 71.2% payout ratio on forecast EPS..

Metrics to watch include Value Cafeteria segment margin and healthcare revenue mix, Consolidated gross margin and cost-of-sales growth relative to revenue growth, Operating-income progress against the ¥1.65bn full-year forecast, Unallocated corporate expenses, Cash and deposits, short-term loans, and the current ratio, Operating cash flow and free-cash-flow coverage of dividends, Work-in-process balance and project billing conversion.

Regarding relative positioning, The company combines recurring HR, health-benefit, and health-insurance administration revenue with an asset-heavy balance sheet. Its Q1 revenue growth is favorable, but a 7.6% operating margin, 7.8% annualized ROE, and sub-1.0x current ratio place the near-term financial profile below that of higher-margin, net-cash IT and HR-service peers. The HR Management segment's improved profitability is constructive, but consolidated relative positioning depends on restoring the core Value Cafeteria business's gross-margin conversion.